Appropriate Duration of Anti-Platelet and Thrombotic Strategy After 12 Months in Patients With Atrial Fibrillation Treated With Drug Eluting Stents
Clinical trial NCT04250116 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04250116
- Sponsor
- Yonsei University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-28
- Primary completion
- 2025-04-01
- Enrollment
- 960
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.